The parent company of Boots is reportedly considering putting its pharmacy chain on the market next year for an estimated £10 billion.
According to Sky News, the US retail giant, Walgreen Boots Alliance (WBA), is lining up Goldman Sachs advisers to look into a potential sale of the pharmacy.
A potential stock market listing could also be considered, as well as a private sale.
Source: Retail Gazette